The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126100502 12610050 2 F 20150625 20160901 20160801 20160907 EXP JP-ROCHE-1613034 ROCHE 16.40 YR F Y 0.00000 20160907 MD JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126100502 12610050 1 PS Rituximab RITUXIMAB 1 Intravenous (not otherwise specified) 103705 500 MG SOLUTION FOR INFUSION
126100502 12610050 2 C PREDONINE PREDNISOLONEPREDNISOLONE ACETATEPREDNISOLONE SODIUM SUCCINATE 1 Oral 0 12.5 MG
126100502 12610050 3 C METHYLPREDNISOLONE SODIUM SUCCINATE. METHYLPREDNISOLONE SODIUM SUCCINATE 1 Intravenous (not otherwise specified) 0 125 MG
126100502 12610050 4 C NEORAL CYCLOSPORINE 1 Oral 0 40 MG
126100502 12610050 5 C NEORAL CYCLOSPORINE 1 Oral 0 30 MG
126100502 12610050 6 C COCARL ACETAMINOPHEN 1 Oral 1.5 TABLETS 0 300 MG
126100502 12610050 7 C NEOMALLERMIN DEXCHLORPHENIRAMINE MALEATE 1 Oral 1 TABLET 0 TABLET
126100502 12610050 8 C ONON PRANLUKAST 1 Oral 0 450 MG
126100502 12610050 9 C TEMOCAPRIL HYDROCHLORIDE TEMOCAPRIL HYDROCHLORIDE 1 Oral 0 1 MG
126100502 12610050 10 C PRAVASTATIN SODIUM. PRAVASTATIN SODIUM 1 Oral 0 5 MG
126100502 12610050 11 C ALLOPURINOL. ALLOPURINOL 1 Oral 0 100 MG
126100502 12610050 12 C ALLOPURINOL. ALLOPURINOL 1 Oral 0 50 MG
126100502 12610050 13 C DIOVAN VALSARTAN 1 Oral 0 20 MG
126100502 12610050 14 C BAKTAR SULFAMETHOXAZOLETRIMETHOPRIM 1 Oral 3 TABLETS 0 TABLET
126100502 12610050 15 C BAKTAR SULFAMETHOXAZOLETRIMETHOPRIM 1 Oral 2 TABLET 0 TABLET
126100502 12610050 16 C CELLCEPT MYCOPHENOLATE MOFETILMYCOPHENOLATE MOFETIL HYDROCHLORIDE 1 Oral 0 1000 MG
126100502 12610050 17 C ALENDRONATE ALENDRONATE SODIUM 1 Oral 0 35 MG TABLET

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126100502 12610050 1 Nephrotic syndrome
126100502 12610050 2 Nephrotic syndrome
126100502 12610050 3 Premedication
126100502 12610050 4 Nephrotic syndrome
126100502 12610050 6 Premedication
126100502 12610050 7 Premedication
126100502 12610050 8 Asthma
126100502 12610050 9 Hypertension
126100502 12610050 10 Hyperlipidaemia
126100502 12610050 11 Hyperuricaemia
126100502 12610050 14 Infection prophylaxis

Outcome of event

Event ID CASEID OUTC COD
126100502 12610050 HO
126100502 12610050 DS

Reactions reported

Event ID CASEID DRUG REC ACT PT
126100502 12610050 Blood creatinine increased
126100502 12610050 Blood urea increased
126100502 12610050 Influenza

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126100502 12610050 1 20150616 20150616 0
126100502 12610050 3 20150616 20150616 0
126100502 12610050 4 20150726 0
126100502 12610050 5 20160727 0
126100502 12610050 6 20150616 20150616 0
126100502 12610050 7 20150616 20150616 0
126100502 12610050 8 20150907 0
126100502 12610050 11 20150817 0
126100502 12610050 12 20150818 20150906 0
126100502 12610050 13 20151014 0
126100502 12610050 14 20150617 20150714 0
126100502 12610050 15 20150715 0